Xla Wt + spib MO has 12 phenotype(s)
Page: 1 2 Next
Images Sources Experiment + Assay Phenotypes Human Diseases
fig.6.b

Costa RM et al. (2008)
Xla Wt + spib MO

NF20 (in situ hybridization)
Expression Phenotype
decreased amount spi1.L expression in anterior ventral blood island
fig.6.k

Costa RM et al. (2008)
Xla Wt + spib MO

NF20 (in situ hybridization)
Expression Phenotype
decreased amount spib.L expression in anterior ventral blood island
fig.6.p

Costa RM et al. (2008)
Xla Wt + spib MO

NF20 (in situ hybridization)
Expression Phenotype
decreased amount mpo.L expression in anterior ventral blood island
fig.6.u

Costa RM et al. (2008)
Xla Wt + spib MO

NF20 (in situ hybridization)
Anatomical Phenotype
abnormal myeloid cell morphology
fig.6.e

Costa RM et al. (2008)
Xla Wt + spib MO

NF22 (in situ hybridization)
Anatomical Phenotype
abnormal development of myeloid cell
Expression Phenotype
decreased amount spi1.L expression in anterior ventral blood island
fig.7.b

Costa RM et al. (2008)
Xla Wt + spib MO

NF22 (in situ hybridization)
Expression Phenotype
decreased amount spib.L expression in anterior ventral blood island
fig.7.e

Costa RM et al. (2008)
Xla Wt + spib MO

NF22 (in situ hybridization)
Expression Phenotype
decreased amount mpo.L expression in anterior ventral blood island
fig.7.h

Costa RM et al. (2008)
Xla Wt + spib MO

NF22 (in situ hybridization)
Expression Phenotype
decreased amount cebpa.L expression in anterior ventral blood island
fig.7.b,e,h

Costa RM et al. (2008)
Xla Wt + spib MO

NF22 (in situ hybridization)
Anatomical Phenotype
abnormally decreased number of myeloid cell
fig.7.k

Costa RM et al. (2008)
Xla Wt + spib MO

NF22 (in situ hybridization)
Expression Phenotype
increased amount tal1.L expression in anterior ventral blood island